956413

Teligent Pharma, Inc. — FEI 1000526875

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 22, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Buena, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)